13 results
8-K
EX-99.1
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
Alexander Eggermont, M.D., Ph.D. Sr. Clinical Advisor Kapil Dhingra, M.D. Strategic R&D Advisor Mads Hald Andersen, M.D., Ph.D. Founder, Scientific
PRE 14A
IOBT
IO Biotech Inc
14 Apr 23
Preliminary proxy
4:39pm
2009 to April 2015, he was Sr Director of Biology and Trans Med at GlaxoSmithKline plc, where he led Oncology R&D teams developing therapeutics from
DEF 14A
6q7ln9r6uftny
14 Apr 22
Definitive proxy
4:02pm
10-K
0zy gdldp
31 Mar 22
Annual report
5:07pm
424B4
wzk03fnv c3s2
8 Nov 21
Prospectus supplement with pricing info
5:20pm
S-1
vxlom0bo74to
15 Oct 21
IPO registration
5:18pm
DRS/A
wa745pxywrsxl1ihoc
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
rf668caeb4
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
8djfoieonb
3 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next